Cases and resources in vascular techniques
This section provides a selection of cases and resources provided by experts in vascular techniques.
Highlights include the safety and effectiveness of percutaneous axillary artery access for complex EVAR, AI-based risk prediction for spinal cord ischemia after EVAR, and the benefits of remote monitoring and blood pressure management after Type B dissection.
Explore key insights into managing carotid artery disease, from stroke risk in asymptomatic patients and tandem lesion strategies to the benefits of routine imaging post-endarterectomy, safe transfemoral CAS tips, challenges of post-radiotherapy stenosis, and the role of IVL for calcified lesions.
Barbara Rantner shares her insights on the ‘Live in the Box - Carotid’ session at #pvi Course 2024, where she delivered a compelling presentation titled ‘Routine completion imaging after carotid endarterectomy makes the difference!’
In this PVI Course 2024 session replay, experts provide an in-depth discussion on the latest approaches to treating aorto-iliac occlusive disease, explore the EVOCC Trial, recent RCTs in vascular surgery, and the role of paclitaxel-coated devices in femoropopliteal interventions, as well as the evolving understanding of limus-based drug-eluting technologies. The session also covers treatment options for long SFA lesions, vessel preparation for endo CFA, and the potential of resorbable scaffolds for ATK and BTK lesions, with key insights from the SOL Japan Trial.
This publication review evaluates treatment trends for acute limb ischemia (ALI) in Japan, comparing the efficacy and safety of endovascular therapy (EVT) versus open surgical revascularization (OSR) using data from the JROAD-DPC database. The study found that, overall, EVT was less effective than OSR for ALI, except in patients with peripheral artery disease (PAD).
This review examines outcomes of endovascular treatment for acute limb ischemia (ALI) using data from a multicenter national registry. It found that patients with pre-existing comorbidities and poor limb viability were more likely to experience adverse outcomes, including mortality and major amputation.
